NPR newsroom chief Edith Chapin says she's leaving the network. She made the announcement just days after Congress voted to strip public broadcasting of all federal funding.

Amylyx is a high-risk biotech targeting rare diseases with strong cash reserves. Key trials soon may drive a 40% stock upside.